A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
Public ClinicalTrials.gov record NCT06340854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Efficacy and Safety of Once-weekly Insulin Icodec When Switching From Daily Basal Insulins Compared to Once-daily Insulin Glargine U100 in Adults With Type 2 Diabetes
Study identification
- NCT ID
- NCT06340854
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 429 participants
Conditions and interventions
Conditions
Interventions
- Insulin glargine Drug
- Insulin icodec Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 18, 2024
- Primary completion
- May 7, 2025
- Completion
- Jun 12, 2025
- Last update posted
- Apr 8, 2026
2024 – 2025
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Investigative Medicine, Inc. | Hawthorne | California | 90250 | — |
| Scripps Whittier Diabetes Inst | La Jolla | California | 92037 | — |
| Clinical Trials Research | Lincoln | California | 95648 | — |
| Northeast Research Institute of Florida | Fleming Island | Florida | 32003 | — |
| South Broward Research LLC | Miramar | Florida | 33027 | — |
| Endo Res Solutions Inc | Roswell | Georgia | 30076 | — |
| Cotton-Oneill Diabetes and End | Topeka | Kansas | 66606-2806 | — |
| International Diabetes Center | Minneapolis | Minnesota | 55416 | — |
| Jefferson City Medical Group, PC | Jefferson City | Missouri | 65109 | — |
| Univ of Nebraska Medical CTR | Omaha | Nebraska | 68198-3020 | — |
| Palm Research Center Inc-Vegas | Las Vegas | Nevada | 89148 | — |
| Southern NH Diabetes and Endo_Nashua | Nashua | New Hampshire | 03060 | — |
| PharmQuest Life Sciences LLC | Greensboro | North Carolina | 27408 | — |
| Accellacare Wilmington | Wilmington | North Carolina | 28401 | — |
| Trial Management Associates | Myrtle Beach | South Carolina | 29572 | — |
| Amarillo Medical Specialists | Amarillo | Texas | 79124 | — |
| Velocity Clinical Res-Dallas | Dallas | Texas | 75230 | — |
| Victorium Clinical Research | Houston | Texas | 77024 | — |
| PlanIt Research, PLLC | Houston | Texas | 77079 | — |
| Chrysalis Clinical Research | St. George | Utah | 84790 | — |
| Rainier Clin Res Ctr Inc | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06340854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06340854 live on ClinicalTrials.gov.